A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Medical Director
Merck Sharp & Dohme LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
267 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 0213)
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Recruiting - Hospital Británico de Buenos Aires-Oncology ( Site 0207)
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Recruiting - Sanatorio Británico-Clinical Oncology Department ( Site 0206)
Rosario, Santa Fe Province, Argentina
Recruiting - Sanatorio Parque ( Site 0205)
Rosario, Santa Fe Province, Argentina
Recruiting - Clínica Mayo de Urgencias Médicas Cruz Blanca S.R.L ( Site 0217)
San Miguel de Tucumán, Tucumán Province, Argentina
Recruiting - Hospital Aleman-Oncology ( Site 0202)
Buenos Aires, Argentina
Recruiting - Hospital Privado Universitario de Córdoba-Hematology and Oncology ( Site 0204)
Córdoba, Argentina
Recruiting
- Westmead Hospital ( Site 0701)
Westmead, New South Wales, Australia
Recruiting - the Prince Charles Hospital ( Site 0700)
Brisbane, Queensland, Australia
Recruiting - Fiona Stanley Hospital-Medical Oncology ( Site 0705)
Murdoch, Western Australia, Australia
Recruiting
- Medizinische Universitaet Innsbruck-Department for Internal Medicine V ( Site 1403)
Innsbruck, Tyrol, Austria
Recruiting - Ordensklinikum Linz Gmbh Elisabethinen-Department of Pneumology ( Site 1402)
Linz, Upper Austria, Austria
Recruiting - Klinik Floridsdorf-Abteilung Für Innere Medizin Und Pneumologie ( Site 1400)
Vienna, Austria
Recruiting - Standort Penzing Der Klinik Ottakring-Abteilung Für Atemwegs-Und Lungenkrankheiten ( Site 1401)
Vienna, Austria
Recruiting
- Antwerp University Hospital-Thoracic Oncology ( Site 1503)
Edegem, Antwerpen, Belgium
Recruiting - Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi ( Site 1502)
Yvoir, Namur, Belgium
Recruiting - Vitaz ( Site 1500)
Sint-Niklaas, Oost-Vlaanderen, Belgium
Recruiting
- Liga Norte Riograndense Contra O Câncer ( Site 0301)
Natal, Rio Grande do Norte, Brazil
Recruiting - Hospital Nossa Senhora Da Conceição ( Site 0302)
Porto Alegre, Rio Grande do Sul, Brazil
Recruiting - Irmandade Da Santa Casa de Misericórdia de Porto Alegre ( Site 0303)
Porto Alegre, Rio Grande do Sul, Brazil
Recruiting - Instituto de Oncologia Saint Gallen ( Site 0319)
Santa Cruz do Sul, Rio Grande do Sul, Brazil
Recruiting - Fundação Pio Xii - Hospital de Câncer de Barretos ( Site 0304)
Barretos, São Paulo, Brazil
Recruiting - Fundação Faculdade Regional de Medicina de São José Do Rio Preto ( Site 0313)
São José do Rio Preto, São Paulo, Brazil
Recruiting - Icesp - Instituto Do Câncer Do Estado de São Paulo ( Site 0305)
São Paulo, Brazil
Recruiting
- Centre Intégré de Santé Et de Services Sociaux de la Montérégie-Centre ( Site 0100)
Greenfield Park, Quebec, Canada
Recruiting - Centre Hospitalier de L'Université de Montréal ( Site 0104)
Montreal, Quebec, Canada
Recruiting - Mcgill University Health Centre ( Site 0105)
Montreal, Quebec, Canada
Recruiting - St. Marys Hospital Center ( Site 0107)
Montreal, Quebec, Canada
Recruiting
- Falp-Uido ( Site 0401)
Providencia, Region M. de Santiago, Chile
Recruiting - Bradfordhill-Clinical Area ( Site 0400)
Santiago, Region M. de Santiago, Chile
Recruiting - Centro de Estudios Clínicos Saga-Cecsaga ( Site 0404)
Santiago, Region M. de Santiago, Chile
Recruiting - Clínica Redsalud Vitacura ( Site 0412)
Santiago, Region M. de Santiago, Chile
Recruiting - Oncocentro Apys-Acerey ( Site 0410)
Viña del Mar, Valparaiso, Chile
Recruiting
- Beijing Cancer Hospital-Thoracic Surgery Department I ( Site 1301)
Beijing, Beijing Municipality, China
Recruiting - Beijing Peking Union Medical College Hospital-Thoracic Surgery Department ( Site 1302)
Beijing, Beijing Municipality, China
Recruiting - Peking University People'S Hospital ( Site 1300)
Beijing, Beijing Municipality, China
Recruiting - Fujian Cancer Hospital-Oncology Department ( Site 1314)
Fuzhou, Fujian, China
Recruiting - Southern Medical University Nanfang Hospital-Thoracic Surgery Department ( Site 1313)
Guangzhou, Guangdong, China
Recruiting - the First Affiliated Hospital of Guangzhou Medical University-Thoracic Surgery Department ( Site 1320)
Guangzhou, Guangdong, China
Recruiting - Henan Cancer Hospital-Henan Cancer Hospital ( Site 1316)
Zhengzhou, Henan, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Apr 2024
- Primary completion
- 21 Feb 2034
- Completion
- 23 Oct 2034
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 780
- Registry id
- NCT06312137
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.